The above binding signals were also used to measure MYC and MAX displacement from their 5′‐ and 3′‐end sites in 22Rv1 prostate cancer cells following exposure to the potent and specific small molecule MYC inhibitor MYCi975 (Figure 1E).[8b] This led to 4 observations. Here, MAX is linked to prostate carcinoma.